Triaziquone
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 2,3,5-tris(aziridin-1-yl)benzo-1,4-quinone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 68-76-8  |
| ATC code | L01AC02 |
| PubChem | CID 6235 |
| UNII | F3D5D9P25I |
| KEGG | C19542 |
| Synonyms | 2,3,5-Tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione |
| Chemical data | |
| Formula | C12H13N3O2 |
| Mol. mass | 231.25 g/mol |
 (what is this?) (verify) |
|
Triaziquone is a drug used in chemotherapy.
It is an alkylating agent. It can react with DNA to form intrastrand crosslinks.[1]
References [edit]
- ^ Begleiter A (November 2000). "Clinical applications of quinone-containing alkylating agents". Front. Biosci. 5: E153–71. doi:10.2741/begleit. PMID 11056078.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
